IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 1247.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 21-Feb-2017
Cancer Epidemiology, Biomarkers & Prevention
Hispanic cancer mortality varies among ethnic groups
Cancer mortality rates vary considerably within the growing Hispanic population in the United States, with significant differences among the major Hispanic ethnic groups.
NIH/National Institute of General Medical Sciences

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research

Public Release: 21-Feb-2017
Radiology
Screening MRI benefits women at average risk of breast cancer
MRI screening improves early diagnosis of breast cancer in all women-not only those at high risk-according to a new study from Germany.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 21-Feb-2017
Radiology
Novel breast tomosynthesis technique reduces screening recall rate
A new digital breast tomosynthesis technique has the potential to reduce the rate at which women are called back for additional examinations without sacrificing cancer detection, according to a new study.

Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America

Public Release: 20-Feb-2017
2017 AAAS Annual Meeting
Decision-making suffers when cancer patients avoid math
Many of the toughest decisions faced by cancer patients involve knowing how to use numbers -- calculating risks, evaluating treatment options and figuring odds of medication side effects. But for patients who aren't good at math, decision science research can offer evidence-based advice on how to assess numeric information and ask the right questions to make informed choices.

Contact: Jeff Grabmeier
grabmeier.1@osu.edu
614-292-8457
Ohio State University

Public Release: 20-Feb-2017
CANCER
Many cancer survivors change their prescription drug use for financial reasons
A new analysis indicates that many cancer survivors change their prescription drug use (including skipping doses or requesting cheaper medications) for financial reasons.

Contact: Dawn Peters
sciencenewsroom@wiley.com
Wiley

Public Release: 20-Feb-2017
JAMA Oncology
SWOG study shows strong long-term survival rates for patients with GIST
Researchers show that nearly one in four patients with incurable gastrointestinal stromal tumors (GIST) treated with Gleevec will survive 10 years. Results are published in JAMA Oncology.
NIH/National Cancer Institute, Novartis Pharmaceuticals

Contact: Wendy Lawton
lawtonw@ohsu.edu
503-348-8675
SWOG

Public Release: 19-Feb-2017
2017 AAAS Annual Meeting
Bringing evidence to health screening debates
At a talk and panel discussion in Boston the morning of Feb. 19, Brown University biostatistician Constantine Gatsonis will discuss how big trials help us make sense of our many questions about cancer screening.

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 19-Feb-2017
2017 AAAS Annual Meeting
When screening for disease, risk is as important to consider as benefits, study indicates
University of Virginia statistician Karen Kafadar is developing new techniques for understanding the difference between length of diagnosis and length of life regarding cancer screening.

Contact: Fariss Samarrai
fls4f@virginia.edu
434-924-3778
University of Virginia

Public Release: 17-Feb-2017
Journal of Experimental Medicine
Tumor suppressor promotes some acute myeloid leukemias, study reveals
Researchers in Germany have discovered that a tumor suppressor protein thought to prevent acute myeloid leukemia (AML) can actually promote a particularly deadly form of the disease. The study, 'RUNX1 cooperates with FLT3-ITD to induce leukemia,' which will be published online Feb. 17 in The Journal of Experimental Medicine, suggests that targeting this protein could be an effective treatment for certain AML patients.
Deutsche Krebshilfe Foundation, Bundesministerium fur Gesundheit, Freie und Hansestadt Hamburg

Contact: Ben Short
bshort@rockefeller.edu
212-327-7053
Rockefeller University Press

Public Release: 17-Feb-2017
2017 AAAS Annual Meeting
Researchers are first to see DNA 'blink'
Northwestern University biomedical engineers have developed imaging technology that is the first to see DNA 'blink,' or fluoresce. The tool enables researchers to study individual biomolecules (DNA, chromatin, proteins) as well as important global patterns of gene expression, which could yield insights into cancer. Vadim Backman will discuss the technology and its applications -- including the new concept of macrogenomics, a technology aiming to regulate the global patterns of gene expression without gene editing -- at the 2017 AAAS annual meeting.

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University

Public Release: 17-Feb-2017
Nature Scientific Reports
Role of rogue protein PAK4 confirmed in pancreatic cancer cells
A new study that confirms the role of a protein called PAK4 in the movement and growth of pancreatic cancer cells could help researchers find new ways to tackle the disease.
Pancreatic Cancer Research Fund

Contact: Beck Lockwood
beck@campuspr.co.uk
Pancreatic Cancer Research Fund

Public Release: 17-Feb-2017
BMJ Open
Quality of life with those with advanced cancer improved through walking
Walking for just 30 minutes three times per week could improve the quality of life for those with advanced cancer, a new study published in the BMJ Open journal has found.

Contact: Natasha Meredith
n.meredith@surrey.ac.uk
01-483-684-380
University of Surrey

Public Release: 16-Feb-2017
Molecular Cell
How cancers trick the immune system into helping rather than harming them
Scientists from Trinity College Dublin have identified a molecule that sends a 'wound-healing' message from tumour cells. If we can disrupt this messaging system, we may be able to fight certain cancers.

Contact: Thomas Deane
deaneth@tcd.ie
353-189-64685
Trinity College Dublin

Public Release: 16-Feb-2017
Science
Scientists reveal the treadmilling motion of dividing bacteria
An international team of scientists using the latest imaging techniques have revealed how bacterial division proteins build a partition wall across the cell, one molecule at a time.

Contact: Helen Rae
helen.rae@ncl.ac.uk
44-019-120-87374
Newcastle University

Public Release: 16-Feb-2017
Cancer Cell
Adenoviruses and the immune system join forces against cancer
IDIBELL researchers have developed an oncolytic virus capable of redirecting the patient's immune system against their tumor cells. Their work may lead to the development of new therapeutic strategies for several types of cancer.
Spanish Ministerio de Economía y Competitividad, Generalitat de Catalunya, European Commission

Contact: Gemma Fornons
gfornons@idibell.cat
0034-638-685-074
IDIBELL-Bellvitge Biomedical Research Institute

Public Release: 16-Feb-2017
Cancer Epidemiology, Biomarkers & Prevention
Site of care may partly explain survival difference between kids and AYAs with leukemia
Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) who were not treated at specialized cancer centers had significantly worse five-year survival compared with children with these cancers who were treated at specialized cancer centers, whereas AYAs treated at specialized cancer centers had outcomes comparable to children treated at specialized cancer centers.
National Institutes of Health, St. Baldrick's Foundation

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research

Public Release: 16-Feb-2017
CA: A Cancer Journal for Clinicians
Report: Clinicians should routinely counsel patients on physical activity
A new study concludes that physical activity should be routinely assessed during every doctor-patient visit.

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Public Release: 16-Feb-2017
Cell Stem Cell
Scientists create novel model that shows progression from normal blood cells to leukemia
Mount Sinai researchers have created a novel model that shows the step-by-step progression from normal blood cells to leukemia and its precursor diseases, creating replicas of the stages of the disease to test the efficacy of therapeutic interventions at each stage, according to a study to be published in Cell Stem Cell. This research marked the first time scientists have been able to transplant leukemia from humans to a test tube and then into mice for study.
NIH/National Heart, Lung, and Blood Institute, NIH/National Institute of Diabetes and Digestive and Kidney Diseases, Damon Runyon Cancer Research Foundation, Edward P. Evans Foundation

Contact: Marlene Naanes
marlene.naanes@mountsinai.org
646-605-7687
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 16-Feb-2017
Nature Communications
Spider web of cancer proteins reveals new drug possibilities
Scientists at Winship Cancer Institute of Emory University have mapped a vast spider web of interactions between proteins in lung cancer cells, as part of an effort to reach what was considered 'undruggable.' This approach revealed new ways to target cells carrying mutations in cancer-causing genes.
NIH/National Cancer Institute, Winship Cancer Institute, Georgia Research Alliance

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 16-Feb-2017
Cell Reports
Looking beyond cancer cells to understand what makes breast cancer spread
A new study from researchers at the University of Michigan Comprehensive Cancer Center identifies a protein in that microenvironment that promotes the spread of breast cancer cells. It's part of a well-known family of receptors for which promising inhibitors are being developed.
National Institutes of Health

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
Michigan Medicine - University of Michigan

Public Release: 16-Feb-2017
IEEE Engineering in Medicine and Biology Society (EMBS) flagship conference International Conference
Real-time MRI analysis powered by supercomputers
Researchers from the Texas Advanced Computing Center, The University of Texas Health Science Center and Philips Healthcare have developed a new, automated platform capable of returning in-depth analyses of MRI scans in a matter of minutes, rather than hours or days. The system has the potential to minimize patient callbacks, save millions annually, and advance precision medicine.
National Science Foundation, National Institutes of Health

Contact: Aaron Dubrow
aarondubrow@tacc.utexas.edu
512-471-8217
University of Texas at Austin, Texas Advanced Computing Center

Public Release: 16-Feb-2017
Cureus
Targeted radiosurgery better than whole-brain radiation for treating brain tumors
Tumors that originate in other organs of the body and spread to the brain are known as metastatic brain tumors. According to the American Brain Tumor Association, this tumor type is the most common in adults, affecting as many as 300,000 people each year. University of Missouri School of Medicine researchers compared two common postsurgical therapies for metastatic brain tumors and found that stereotactic radiosurgery can provide better outcomes for patients compared to whole-brain radiation.
American Brain Tumor Association, University of Missouri School of Medicine Office of Medical Research

Contact: Derek Thompson
thompsonder@health.missouri.edu
573-882-3323
University of Missouri-Columbia

Public Release: 16-Feb-2017
JCI Insight
Doctors treat deadly cancerous disorders with gene-guided, targeted therapy
Genomic testing of biopsies from patients with deadly, treatment-resistant cancerous blood syndromes called histiocytoses allowed doctors to identify genes fueling the ailments and use targeted molecular drugs to successfully treat them. Researchers report their data in Journal of Clinical Investigation Insight (JCI Insight). They recommend the regular use of comprehensive genomic profiling at diagnosis to positively impact clinical care.

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center

Public Release: 16-Feb-2017
BMC Biology
Targeting the biological clock could slow the progression of cancer
Does the biological clock in cancer cells influence tumour growth? Yes, according to a study conducted by Nicolas Cermakian, a professor in McGill University's Department of Psychiatry.

Contact: Bruno Geoffroy
relations.medias.comtl@ssss.gouv.qc.ca
514-630-2225 x5257
McGill University

Public Release: 15-Feb-2017
Science Translational Medicine
Scientifically-designed fasting diet lowers risks for major diseases
Results of a randomized clinical trial shows a periodic, five-day fasting diet designed by a USC researcher safely reduced the risk factors for heart disease, cancer, diabetes and other age-related diseases.
USC Edna M. Jones Chair in Gerontology fund, National Institutes of Health

Contact: Emily Gersema
gersema@usc.edu
213-740-0252
University of Southern California

Showing releases 1-25 out of 1247.

1 | 2 | 3 | 4 | 5 > >>

  Search News Releases

     

 

EurekAlert!